来源：新浪港股-好仓工作室 7月11日，可孚医疗发布公告，宣布董事会已审议通过授权管理层启动境外发行H股并在香港联交所上 市的前期筹备工作。 公司经营：市场竞争激烈，产品结构待优化 从财务数据来看，可孚医疗近年来的业绩表现并不理想。2024年，公司实现营业收入29.83亿元，同比 增长4.53%，增速较以往明显放缓。净利润方面，虽然实现了3.12亿元，同比增长22.6%，但这主要得益 于成本控制和费用优化，并非来自于核心业务的强劲增长。进入2025年，公司业绩更是出现了下滑迹 象，一季度营业收入为7.38亿元，同比减少8.59%；净利润为9143万元，同比减少9.68%。 | 截止日期 | | 2022-12-31 | 2023-12-31 | 2024-12-31 | | --- | --- | --- | --- | --- | | 报告期 | | 年报 | 年报 | 年报 | | 报表类型 | | 合井报表 | 合井报表 | 合井报表 | | ▽ 利润表摘要 | | | | | | 营业总收入 | = | 29.77 | 28.54 | 29.83 | | 同比(%) | 11 0 | 30.82 | ...

Core Viewpoint - Jiangsu province is showcasing its development vitality through the "Su Chao" trend, with county-level sectors significantly contributing to nearly half of the province's economic output, emphasizing high-quality development and innovative paths for new productive forces [1] Group 1: Current Landscape of New Productive Forces in Jiangsu Counties - Jiangsu's counties exhibit a spatial pattern of "South Strong, Central Rising, North Advancing," forming a collaborative "geese formation" across the province [2] - The southern region, as an innovation hub, houses over 7,000 enterprises related to new productive forces, with Kunshan, Jiangyin, and Zhangjiagang leading as top counties [2] - Kunshan stands out with over 1,000 enterprises in traditional industry transformation, while Suzhong and Subei regions are also making significant strides in developing new productive forces [2] Group 2: Resilience in Transitioning Old and New Energies - Jiangsu counties are achieving a "multi-level jump" in industrial capability through a dual drive of "renewing traditional energy and laying out new tracks" [3] - Traditional industries are undergoing digital transformation, with notable examples like Changshu's Bosideng integrating AI and big data into textile production [3] - Emerging industries such as new energy vehicles and biomedicine are becoming key development areas, with companies like Yuyue Group leading in the medical device sector [3] Group 3: Collaborative Innovation Ecosystem - Jiangsu counties are breaking through development limitations by building a collaborative innovation ecosystem that attracts innovative resources [4] - The market-oriented operation model of industry-university-research collaboration has shown significant results, with Kunshan's technology spending reaching 10% of public budget expenditures [4] - The establishment of advanced research institutes in collaboration with institutions like the Chinese Academy of Sciences has led to the emergence of leading enterprises in the energy sector [4] Group 4: Institutional Innovation Driving Growth - Institutional innovations are releasing development momentum, with counties like Kunshan focusing on talent acquisition and land resource efficiency [5] - Initiatives such as the "Funiing Filter Material Festival" have successfully created specialized service environments for emerging industries [5] Group 5: Recommendations for Further Development - Strengthening top-level design and coordination for county-level economic integration into the regional development framework is essential [6][7] - Encouraging differentiated development based on regional characteristics and optimizing resource allocation will enhance county-level economic performance [7] - Building a robust innovation ecosystem and enhancing the effectiveness of science and technology-driven initiatives are critical for future growth [8][9][10]

Group 1: Nuclear Power Industry - The State Council approved the construction of 10 nuclear power units, indicating a positive long-term growth outlook for the nuclear power sector in China [2][4][6] - From 2022 to 2025, China has consistently approved at least 10 nuclear power units annually, with a total of 44 units under construction as of April 2025, representing a significant increase in installed capacity [3][4] - Nuclear power is recognized as a clean and stable baseload energy source, with high utilization hours and relatively stable electricity prices, which are expected to drive revenue and profit growth for related companies [4][5][6] Group 2: ASEAN Economic Cooperation - The visit of President Xi Jinping to ASEAN countries marks a significant moment for deepening cooperation in trade, investment, and industry, contributing positively to regional and global economic development [8][9] - China and ASEAN are focusing on high-end manufacturing, mineral resource development, infrastructure cooperation, and agricultural consumption, aiming for mutual benefits and deeper integration of industrial chains [10][9] - The cooperation framework includes enhancing policy coordination, leveraging complementary advantages in technology and market, and improving trade and investment facilitation to stimulate regional growth [10][9] Group 3: Precious Metals Market - Recent signals from the U.S. government regarding easing trade tensions with China have led to a temporary decline in gold prices, but medium-term prospects for gold prices remain bullish due to ongoing geopolitical risks and potential economic downturns in the U.S. [13][15] - Global gold ETF holdings and central bank purchases, particularly from emerging markets, indicate significant room for further accumulation of gold, supporting price increases [15][13] - The copper and aluminum sectors are expected to rebound due to favorable macroeconomic policies and a shift in market sentiment following the easing of trade tensions [15][16] Group 4: Agricultural Sector - He Feng Co. - He Feng Co. reported a significant turnaround in profitability for 2024, with a net profit of 3.42 billion yuan, compared to a loss in the previous year, driven by cost reduction and efficiency improvements [18][19] - The company’s feed business faced challenges with a decline in sales volume and price, but the meat and poultry segments showed resilience and growth potential [19][20] - The company plans to achieve over 10% growth in feed sales in 2025, focusing on strategic transformations across product, channel, and management aspects [19][22] Group 5: Medical Devices - Yuyue Medical - Yuyue Medical's revenue for 2024 decreased by 5.09%, but the company is focusing on strategic investments to accelerate international expansion, particularly in the blood glucose management sector [24][25] - The Continuous Glucose Monitoring (CGM) technology is identified as a key growth driver, with new products expected to significantly increase market penetration [27][29] - The company has made a strategic investment in Inogen to enhance its presence in the U.S. and European markets, indicating a commitment to long-term growth and shareholder returns [28][29]